Hyperkalemia

"Hyperkalemia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Abnormally high potassium concentration in the blood, most often due to defective renal excretion. It is characterized clinically by electrocardiographic abnormalities (elevated T waves and depressed P waves, and eventually by atrial asystole). In severe cases, weakness and flaccid paralysis may occur. (Dorland, 27th ed)

Descriptor ID	D006947
MeSH Number(s)	C18.452.950.396
Concept/Terms	Hyperkalemia Hyperkalemia Hyperkalemias Hyperpotassemia Hyperpotassemias

Below are MeSH descriptors whose meaning is more general than "Hyperkalemia".

Diseases [C]
Nutritional and Metabolic Diseases [C18]
Metabolic Diseases [C18.452]
Water-Electrolyte Imbalance [C18.452.950]
Hyperkalemia [C18.452.950.396]

Below are MeSH descriptors whose meaning is related to "Hyperkalemia".

Below are MeSH descriptors whose meaning is more specific than "Hyperkalemia".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Hyperkalemia" by people in this website by year, and whether "Hyperkalemia" was a major or minor topic of these publications.

Bar chart showing 12 publications over 9 distinct years, with a maximum of 2 publications in 2011 and 2012 and 2019

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2002	1	0	1
2009	1	0	1
2011	0	2	2
2012	2	0	2
2014	1	0	1
2018	1	0	1
2019	0	2	2
2022	1	0	1
2024	1	0	1

Below are the most recent publications written about "Hyperkalemia" by people in Profiles.

Zhao MH, Chen W, Cheng H, Liu BC, Mao ZG, Tian Z, Xu G, Zhou JM. A Chinese Multi-Specialty Delphi Consensus to Optimize RAASi Usage and Hyperkalaemia Management in Patients with Chronic Kidney Disease and Heart Failure. Chin Med Sci J. 2024 Jun 30; 39(2):79-90.

View in: PubMed
Prabhudesai D, Davis J, Chen JJ, Lim E. Potentially preventable hospitalizations and super-utilization of inpatient services among patients with chronic kidney disease in Hawai'i. BMC Nephrol. 2022 12 23; 23(1):409.

View in: PubMed
Chen N, Hao C, Liu BC, Lin H, Wang C, Xing C, Liang X, Jiang G, Liu Z, Li X, Zuo L, Luo L, Wang J, Zhao MH, Liu Z, Cai GY, Hao L, Leong R, Wang C, Liu C, Neff T, Szczech L, Yu KP. Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis. N Engl J Med. 2019 09 12; 381(11):1011-1022.

View in: PubMed
Chen N, Hao C, Peng X, Lin H, Yin A, Hao L, Tao Y, Liang X, Liu Z, Xing C, Chen J, Luo L, Zuo L, Liao Y, Liu BC, Leong R, Wang C, Liu C, Neff T, Szczech L, Yu KP. Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis. N Engl J Med. 2019 09 12; 381(11):1001-1010.

View in: PubMed
Tamargo M, Tamargo J. New potassium binders reduce the risk of hyperkalaemia in patients treated with renin-angiotensin-aldosterone system inhibitors. Eur Heart J Cardiovasc Pharmacother. 2018 10 01; 4(4):193-194.

View in: PubMed
Maiwall R, Kumar S, Sharma MK, Wani Z, Ozukum M, Sarin SK. Prevalence and prognostic significance of hyperkalemia in hospitalized patients with cirrhosis. J Gastroenterol Hepatol. 2016 May; 31(5):988-94.

View in: PubMed
Suarez-Rivera M, Bonilla-Felix M. Fluid and electrolyte disorders in the newborn: sodium and potassium. Curr Pediatr Rev. 2014; 10(2):115-22.

View in: PubMed
Yanagihara AA, Shohet RV. Cubozoan venom-induced cardiovascular collapse is caused by hyperkalemia and prevented by zinc gluconate in mice. PLoS One. 2012; 7(12):e51368.

View in: PubMed
Alderman MH, Piller LB, Ford CE, Probstfield JL, Oparil S, Cushman WC, Einhorn PT, Franklin SS, Papademetriou V, Ong ST, Eckfeldt JH, Furberg CD, Calhoun DA, Davis BR. Clinical significance of incident hypokalemia and hyperkalemia in treated hypertensive patients in the antihypertensive and lipid-lowering treatment to prevent heart attack trial. Hypertension. 2012 May; 59(5):926-33.

View in: PubMed
Epstein M, Calhoun DA. Aldosterone blockers (mineralocorticoid receptor antagonism) and potassium-sparing diuretics. J Clin Hypertens (Greenwich). 2011 Sep; 13(9):644-8.

View in: PubMed

People

Explore

Similar Concepts

Top Journals